Effective for the vaccination of healthy cats 9 weeks of age or older against feline leukemia virus (FeLV).
Features & Benefits
The only FeLV vaccine that induces anti-FOCMA (feline oncornavirus-associated cell membrane antigen) antibodies
The Anti-FOCMA antibodies have been shown to help confer immunity to FeLV related neoplasia and aid in successful resistance to tumor development
Contains patented Gentle Safe-Quil™ adjuvant, which contributes to an optimal introduction of the antigens to the cat’s immune system, helps stimulate a strong antibody response, and is aluminum-free
Uses Leukocell® 2 master seed that is time-tested for efficacy and safety for over 30 years